Professor Robert A Hegele
Disclosure details
Robert A Hegele reports consulting fees from Acasti, Aegerion, Akcea/Ionis, Amgen, HLS Therapeutics, Novartis, Pfizer, Regeneron and Sanofi.Jacob J. Wolfe Distinguished Medical Research Chair,
Martha Blackburn Chair in Cardiovascular Research,
Distinguished University Professor of Medicine and Biochemistry, University of Western Ontario, Canada
Rob Hegele is a staff endocrinologist who cares for > 2500 patients at the lipid clinic at University Hospital, London Ontario.
He holds the Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Chair in Human Genetics and the Blackburn Chair in Cardiovascular Research at Western University.
He was first in North America to use 5 medications that are now routinely prescribed to treat high cholesterol or diabetes.
He has published 780 papers, which have been cited >33,000 times and is in the Clarivate top 1% of highly cited scientists. The website expertscape.com in 2020 ranked him #1 globally in the area of “hypertriglyceridemia” and #2 for “disorders of lipid metabolism”. He received the 2019 American Heart Association Lyman Duff Award and the 2020 FH Foundation Pioneer Award.
He has co-authored many clinical practice guidelines for cholesterol, blood pressure and diabetes. He has trained numerous physicians, medical students and graduate students.
